New schizophrenia drug.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D005260:Female; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone